MedPath

APOLLO HOSPITALS ENTERPRISE LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

12

Active:0
Completed:2

Trial Phases

4 Phases

Phase 2:2
Phase 3:2
Phase 4:3
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (30.0%)
Phase 4
3 (30.0%)
Phase 2
2 (20.0%)
Phase 3
2 (20.0%)
No trials found

News

Apollo Hospitals Invests Rs 573 Crore in Advanced Proton Therapy Oncology Center in Gurugram

Apollo Hospitals announces a Rs 573 crore investment to establish a 100-bed Comprehensive Oncology Centre in Gurugram featuring the Proteus One single gantry Proton Beam Therapy system.

Apollo Hospitals and Siemens Healthineers Launch AI-Driven Research Collaboration for Liver Disease Diagnostics in India

Apollo Hospitals and Siemens Healthineers have established a research collaboration to develop AI-enabled diagnostic and imaging solutions for liver disease management, focusing on quantitative ultrasound imaging and clinical decision support tools.

Advent International Invests $175 Million in Animal Health Generics Company Felix Pharmaceuticals

Advent International has signed a definitive agreement to invest $175 million for a significant minority stake in Felix Pharmaceuticals, a Dublin-based company developing generic medicines for companion animals.

Elucidata and Sapien Biosciences Form Strategic Partnership to Transform India's Largest Biobank into AI-Ready Data Platform

Elucidata and Sapien Biosciences announced a strategic partnership to convert Sapien's 300,000+ patient sample biobank into AI-ready, multimodal data products for drug discovery and diagnostic development.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.